AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20186402 — intervention group
Group type: COMPARATOR
Intervention: Kinetic guidance
Number of subjects: 39
Study 20186402 — intervention group
Group type: COMPARATOR
Intervention: Visual guidance
Number of subjects: 39
Study 17105795 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (60 to 64 Gy of external beam radiotherapy delivered to the prostatic fossa)
Number of subjects: 425
Study 17105795 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus observation
Number of subjects: 425
Study 17105795 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy
Number of subjects: 425
Study 15531687 — intervention group
Group type: EXPERIMENTAL
Intervention: Total calcium intake (>1767 mg/d)
Number of subjects: 3696
Study 15531687 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplement use (>1200 mg/d)
Number of subjects: 3696
Study 15531687 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake (total and supplemental)
Number of subjects: 3696
Study 11374604 — intervention group
Group type: COMPARATOR
Intervention: 0 microg/kg intrathecal morphine (saline injection)
Number of subjects: 30
Study 11374604 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 microg/kg intrathecal morphine
Number of subjects: 30
Study 11374604 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 microg/kg intrathecal morphine
Number of subjects: 30
Study 9331007 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 2 mg
Number of subjects: 1482
Study 9331007 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 4 mg
Number of subjects: 1482
Study 9331007 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 8 mg
Number of subjects: 1482
Study 9331007 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 16 mg
Number of subjects: 1482
Study 9331007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1482
Study 8488994 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg amiphenazole
Number of subjects: 30
Study 8488994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 3547126 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (6 mg per kilogram of body weight per day)
Number of subjects: 20
Study 3547126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30741813 — intervention group
Group type: EXPERIMENTAL
Intervention: IV acetaminophen (1,000 mg)
Number of subjects: 204
Study 30741813 — intervention group
Group type: COMPARATOR
Intervention: Placebo (preoperative saline)
Number of subjects: 204
Study 29217001 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum-chromium everolimus-eluting stent (PtCr-EES)
Number of subjects: 1530
Study 29217001 — intervention group
Group type: COMPARATOR
Intervention: Cobalt-chromium everolimus-eluting stent (CoCr-EES)
Number of subjects: 1530
Study 29217001 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum-chromium everolimus-eluting stent (PtCr-EES) in small vessels
Number of subjects: 1530
Study 29217001 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum-chromium everolimus-eluting stent (PtCr-EES) in long lesions
Number of subjects: 1530
Study 26293644 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-delivered TES intervention
Number of subjects: 141
Study 26293644 — intervention group
Group type: COMPARATOR
Intervention: Traditional intervention delivered by a prevention specialist
Number of subjects: 141
Study 24309584 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily language rehabilitation for 2 weeks (starting 2.2 days poststroke)
Number of subjects: 12
Study 24309584 — intervention group
Group type: COMPARATOR
Intervention: No rehabilitation
Number of subjects: 12
Study 24309584 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily language rehabilitation
Number of subjects: 12
Study 22951346 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically Heated Cigarette Smoking System (EHCSS) and EHCSS‐K3 cigarette (3mg tar, 0.2mg nicotine, and 0.6 mg CO)
Number of subjects: 72
Study 22951346 — intervention group
Group type: EXPERIMENTAL
Intervention: No smoking
Number of subjects: 72
Study 22951346 — intervention group
Group type: COMPARATOR
Intervention: Lark One cigarettes
Number of subjects: 72
Study 19567902 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity assertive community treatment (ACT)
Number of subjects: 0
Study 19567902 — intervention group
Group type: COMPARATOR
Intervention: Usual care from community mental health teams
Number of subjects: 0
Study 17550442 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser treatment
Number of subjects: 10
Study 17550442 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment
Number of subjects: 10
Study 17550442 — intervention group
Group type: COMPARATOR
Intervention: Both laser treatments
Number of subjects: 10
Study 16252540 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-bottle adhesive system with compomer
Number of subjects: 36
Study 16252540 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-bottle adhesive system with packable composite
Number of subjects: 36
Study 16252540 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-bottle adhesive system with amalgam
Number of subjects: 36
Study 16252540 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-bottle adhesive system with all materials
Number of subjects: 36
Study 12197375 — intervention group
Group type: EXPERIMENTAL
Intervention: Active labour
Number of subjects: 40
Study 12197375 — intervention group
Group type: COMPARATOR
Intervention: Control (not in labour)
Number of subjects: 40
Study 10362451 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CR, 5 g creatine monohydrate + 3 g dextrose)
Number of subjects: 10
Study 10362451 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CR)
Number of subjects: 10
Study 10362451 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation (PLA, 7 g dextrose)
Number of subjects: 10
Study 7780117 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral neck fracture group
Number of subjects: 102
Study 7780117 — intervention group
Group type: EXPERIMENTAL
Intervention: Intertrochanteric fracture group
Number of subjects: 102
Study 7780117 — intervention group
Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 102
Study 2180536 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 56
Study 2180536 — intervention group
Group type: COMPARATOR
Intervention: Control (Saline)
Number of subjects: 56
Study 94528 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextranomer beads
Number of subjects: 0
Study 94528 — intervention group
Group type: COMPARATOR
Intervention: Saline dressings
Number of subjects: 0
Study 29064315 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichuris suis (TSO) treatment
Number of subjects: 16
Study 29064315 — intervention group
Group type: COMPARATOR
Intervention: Baseline versus treatment (BVT) control
Number of subjects: 16
Study 26608038 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-based Brain-Gym concept
Number of subjects: 0
Study 26608038 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 25730417 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives delivered contingent on smoking abstinence
Number of subjects: 236
Study 25730417 — intervention group
Group type: COMPARATOR
Intervention: Control condition (incentives delivered independent of smoking status)
Number of subjects: 236
Study 23645837 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with VT
Number of subjects: 4480
Study 23645837 — intervention group
Group type: COMPARATOR
Intervention: Partner controls
Number of subjects: 4480
Study 23645837 — intervention group
Group type: COMPARATOR
Intervention: RDD controls
Number of subjects: 4480
Study 21291510 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-obturator tape (TOT)
Number of subjects: 194
Study 21291510 — intervention group
Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 194
Study 19821873 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy plus caregiver education in rehabilitation (strategy 1, S1)
Number of subjects: 110
Study 19821873 — intervention group
Group type: COMPARATOR
Intervention: Education alone (strategy 2, S2)
Number of subjects: 110
Study 17010306 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help (GSH)
Number of subjects: 49
Study 17010306 — intervention group
Group type: COMPARATOR
Intervention: Pure self-help (PSH)
Number of subjects: 49
Study 14764173 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-down method
Number of subjects: 44
Study 14764173 — intervention group
Group type: COMPARATOR
Intervention: Binary search method
Number of subjects: 44
Study 12040348 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensinogen M235T genotype in hypertensive patients
Number of subjects: 605
Study 12040348 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensinogen M235T genotype in normotensive patients
Number of subjects: 605
Study 12040348 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensinogen gene variation
Number of subjects: 605
Study 9734653 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine (30 mg/kg/d)
Number of subjects: 131
Study 9734653 — intervention group
Group type: COMPARATOR
Intervention: Control (no quinine)
Number of subjects: 131
Study 7983237 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses of NM441 (20, 50, 100, 200, and 400 mg)
Number of subjects: 0
Study 7983237 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of NM441 (300 mg twice daily for 6.5 days)
Number of subjects: 0
Study 7983237 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses of NM441 (100, 200, and 400 mg)
Number of subjects: 0
Study 7983237 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses of NM441 (400 mg)
Number of subjects: 0
Study 7983237 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses of NM441
Number of subjects: 0
Study 7983237 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of NM441
Number of subjects: 0
Study 2648779 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with all three risk characteristics (no history of previous angina or myocardial infarction, ST segment elevation or signs of Q wave development, peak MB-creatine kinase value ≥ 150 IU/L)
Number of subjects: 849
Study 2648779 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 849
Study 773016 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estrogen Quinestrol
Number of subjects: 0
Study 773016 — intervention group
Group type: COMPARATOR
Intervention: Injected drug
Number of subjects: 0
Study 31955207 — intervention group
Group type: EXPERIMENTAL
Intervention: History of pregnancy and infertility (n = 147)
Number of subjects: 2085
Study 31955207 — intervention group
Group type: EXPERIMENTAL
Intervention: History of pregnancy without infertility (n = 736)
Number of subjects: 2085
Study 31955207 — intervention group
Group type: COMPARATOR
Intervention: Nulligravid women without infertility (n = 173)
Number of subjects: 2085
Study 31955207 — intervention group
Group type: EXPERIMENTAL
Intervention: Nulligravid women with histories of infertility (n = 19)
Number of subjects: 2085
Study 31955207 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal women (n = 1010)
Number of subjects: 2085
Study 31955207 — intervention group
Group type: EXPERIMENTAL
Intervention: Infertility or pregnancy
Number of subjects: 2085
Study 31004346 — intervention group
Group type: COMPARATOR
Intervention: ACT-709478 (1-400 mg)
Number of subjects: 65
Study 31004346 — intervention group
Group type: COMPARATOR
Intervention: ACT-709478 (60 mg)
Number of subjects: 65
Study 31004346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 29135373 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin 1,050 mg/day
Number of subjects: 62
Study 29135373 — intervention group
Group type: COMPARATOR
Intervention: Silymarin 420 mg/day
Number of subjects: 62
Study 26653096 — intervention group
Group type: EXPERIMENTAL
Intervention: Video laryngoscopy
Number of subjects: 809
Study 26653096 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 809
Study 22753022 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO + danazol
Number of subjects: 140
Study 22753022 — intervention group
Group type: COMPARATOR
Intervention: danazol
Number of subjects: 140
Study 22753022 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO (given to control group patients in second phase)
Number of subjects: 140
Study 20035173 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadricortical syndesmotic screw fixation (n = 23)
Number of subjects: 48
Study 20035173 — intervention group
Group type: COMPARATOR
Intervention: Tricortical syndesmotic screw fixation (n = 25)
Number of subjects: 48
Study 20035173 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study 20035173 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients (BMI > 30 kg/m2)
Number of subjects: 48
Study 18773994 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline cardiopulmonary exercise test 1
Number of subjects: 398
Study 18773994 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline cardiopulmonary exercise test 2
Number of subjects: 398
Study 18773994 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-subject absolute change in pVo2
Number of subjects: 398
Study 18773994 — intervention group
Group type: EXPERIMENTAL
Intervention: Other parameters (ventilation-to-carbon-dioxide production slope, Vo2 at ventilatory threshold)
Number of subjects: 398
Study 15975107 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 182
Study 15975107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study 14571350 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine ER (75 mg, could be increased to 150 mg)
Number of subjects: 160
Study 14571350 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline ER (75 mg, could be increased to 150 mg)
Number of subjects: 160
Study 10500015 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day protein-free diet
Number of subjects: 11
Study 10500015 — intervention group
Group type: COMPARATOR
Intervention: 5-day diet providing adequate nitrogen and amino acids except for sulfur amino acids (SAAs) or leucine
Number of subjects: 11
Study 8943593 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine phosphate 60 mg
Number of subjects: 40
Study 8943593 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine sulphate 10 mg
Number of subjects: 40
Study 8943593 — intervention group
Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 40
Study 1816937 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanic cavity wash tubes (grommets) inserted (26%) or myringotomy (10%) after persistence of middle ear effusions for more than 3 months
Number of subjects: 184
Study 1816937 — intervention group
Group type: COMPARATOR
Intervention: Grommets inserted as a primary treatment
Number of subjects: 184
Study 6220335 — intervention group
Group type: EXPERIMENTAL
Intervention: Duxil
Number of subjects: 39
Study 6220335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 30742868 — intervention group
Group type: EXPERIMENTAL
Intervention: LCAG secured with autogenous serum in-situ
Number of subjects: 60
Study 30742868 — intervention group
Group type: COMPARATOR
Intervention: LCAG secured with sutures
Number of subjects: 60
Study 27543915 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral intervention (control condition)
Number of subjects: 108
Study 27524691 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm blocks (ultrasound-guided median, ulnar, and radial nerve blocks at the mid to proximal forearm)
Number of subjects: 60
Study 27524691 — intervention group
Group type: COMPARATOR
Intervention: Brachial plexus blocks (ultrasound-guided supraclavicular, infraclavicular, or axillary nerve block)
Number of subjects: 60
Study 27524691 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm blocks
Number of subjects: 60
Study 27524691 — intervention group
Group type: COMPARATOR
Intervention: Brachial plexus blocks
Number of subjects: 60
Study 24275098 — intervention group
Group type: COMPARATOR
Intervention: Dolutegravir 50 mg as a tablet
Number of subjects: 0
Study 24275098 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg in 10 g of granule administered directly to mouth
Number of subjects: 0
Study 24275098 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg in 10 g of granule mixed with purified water
Number of subjects: 0
Study 24275098 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg in 10 g of granule mixed with water containing high cation concentrations
Number of subjects: 0
Study 24275098 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg in 10 g of granule mixed with milk-based infant formula
Number of subjects: 0
Study 21904859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethylene oxide (EO) gas sterilization
Number of subjects: 70
Study 21904859 — intervention group
Group type: COMPARATOR
Intervention: Autoclaving
Number of subjects: 70
Study 19653268 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 829
Study 19653268 — intervention group
Group type: COMPARATOR
Intervention: No Prednisolone
Number of subjects: 829
Study 16815036 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptual problem-solving task
Number of subjects: 0
Study 16815036 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal intelligence
Number of subjects: 0
Study 16815036 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing style
Number of subjects: 0
Study 16815036 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit knowledge
Number of subjects: 0
Study 16815036 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality measures
Number of subjects: 0
Study 16313289 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir
Number of subjects: 175
Study 16313289 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine and Lamivudine
Number of subjects: 175
Study 16313289 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine, Lamivudine and Indinavir
Number of subjects: 175
Study 15592220 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbond Plus (3M/ Unitek)
Number of subjects: 270
Study 15592220 — intervention group
Group type: EXPERIMENTAL
Intervention: First Step (Reliance Orthodontic Products)
Number of subjects: 270
Study 15592220 — intervention group
Group type: COMPARATOR
Intervention: Transbond XT (3M/ Unitek)
Number of subjects: 270
Study 10989902 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic skills training using simulated tasks on a video-trainer for 30 minutes daily for 10 days
Number of subjects: 27
Study 10989902 — intervention group
Group type: COMPARATOR
Intervention: No formal training (Control group)
Number of subjects: 27
Study 8772687 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (n = 40)
Number of subjects: 77
Study 8772687 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 37)
Number of subjects: 77
Study 1463596 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 mg/Kg/die of reduced glutathione (GSH)
Number of subjects: 40
Study 1463596 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 40
Study 6531440 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine HCl (0.25, 0.5 or 0.75 mg sc)
Number of subjects: 9
Study 6531440 — intervention group
Group type: COMPARATOR
Intervention: Benztropine (2 mg iv)
Number of subjects: 9
Study 31842106 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical therapy twice a week (P2 group)
Number of subjects: 124
Study 31842106 — intervention group
Group type: COMPARATOR
Intervention: Supervised physical therapy once a week (P1 group)
Number of subjects: 124
Study 31842106 — intervention group
Group type: COMPARATOR
Intervention: Home exercise program alone (HE group)
Number of subjects: 124
Study 31136089 — intervention group
Group type: EXPERIMENTAL
Intervention: CART analysis predicting plan quality
Number of subjects: 200
Study 28447362 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm pulsed dye laser (PDL) treatment (fluence 8 J/cm3, pulse duration 10 ms, spot size 7 mm, 2 sessions every 2 weeks)
Number of subjects: 30
Study 28447362 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm pulsed dye laser (PDL) treatment
Number of subjects: 30
Study 25861793 — intervention group
Group type: EXPERIMENTAL
Intervention: Photographic art in exam rooms
Number of subjects: 117
Study 25861793 — intervention group
Group type: COMPARATOR
Intervention: Standard medical posters (control room)
Number of subjects: 117
Study 23561694 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 8.75 mg microgranules
Number of subjects: 373
Study 23561694 — intervention group
Group type: COMPARATOR
Intervention: Placebo microgranules
Number of subjects: 373
Study 21168109 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture (TCA) weekly for 5 weeks
Number of subjects: 18
Study 21168109 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention only (practitioner present and participant supine) weekly for 5 weeks
Number of subjects: 18
Study 21168109 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 18
Study 19063649 — intervention group
Group type: EXPERIMENTAL
Intervention: Established guidelines plus the DASH diet (increased fruits, vegetables, low-fat dairy, reduced fat)
Number of subjects: 810
Study 19063649 — intervention group
Group type: EXPERIMENTAL
Intervention: Established guidelines for blood pressure control (reduced sodium, increased physical activity)
Number of subjects: 810
Study 19063649 — intervention group
Group type: COMPARATOR
Intervention: Advice‐Only
Number of subjects: 810
Study 19063649 — intervention group
Group type: EXPERIMENTAL
Intervention: Established plus DASH
Number of subjects: 810
Study 17928991 — intervention group
Group type: EXPERIMENTAL
Intervention: Urate oxidase (1.5 mg)
Number of subjects: 20
Study 17928991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15110879 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy followed by myeloablative chemotherapy and autologous stem-cell rescue
Number of subjects: 0
Study 15110879 — intervention group
Group type: COMPARATOR
Intervention: Intensive chemotherapy alone
Number of subjects: 0